VE
INSIDER · 2 COMPANIES · CHIEF EXECUTIVE OFFICER
Venker Eric
Every open-market transaction filed under this name, Aug 28 to Oct 2. The same name appears at more than one issuer; filings don’t say whether it’s one person.
Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$14.6M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 2 | IMVT | Immunovant, Inc. | Chief Executive Officer | Sell | 3,506 | $34.11 | $120K | −18.2% |
| Sep 30 | ROIV | Roivant Sciences Ltd. | President & Immunovant CEO | Sell | 200,000 | $36.62 | $7.3M | — |
| Aug 28 | ROIV | Roivant Sciences Ltd. | President & Immunovant CEO | Sell | 33,818 | $36.44 | $1.2M | — |
| Aug 28 | ROIV | Roivant Sciences Ltd. | President & Immunovant CEO | Sell | 166,182 | $35.63 | $5.9M | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.